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Abstract: In most animals, transient increases of extracellular ATP (ATPe) are used for physiological
signaling or as a danger signal in pathological conditions. ATPe dynamics are controlled by ATP
release from viable cells and cell lysis, ATPe degradation and interconversion by ecto-nucleotidases,
and interaction of ATPe and byproducts with cell surface purinergic receptors and purine salvage
mechanisms. Infection by protozoan parasites may alter at least one of the mechanisms controlling
ATPe concentration. Protozoan parasites display their own set of proteins directly altering ATPe
dynamics, or control the activity of host proteins. Parasite dependent activation of ATPe conduits
of the host may promote infection and systemic responses that are beneficial or detrimental to the
parasite. For instance, activation of organic solute permeability at the host membrane can support the
elevated metabolism of the parasite. On the other hand ecto-nucleotidases of protozoan parasites, by
promoting ATPe degradation and purine/pyrimidine salvage, may be involved in parasite growth,
infectivity, and virulence. In this review, we will describe the complex dynamics of ATPe regulation
in the context of protozoan parasite–host interactions. Particular focus will be given to features of
parasite membrane proteins strongly controlling ATPe dynamics. This includes evolutionary, genetic
and cellular mechanisms, as well as structural-functional relationships.
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1. Introduction
Adenosine 5′ triphosphate, ATP, is usually described as an essential energy source for cells.
ATP hydrolysis provides the energy required for many chemical reactions of metabolism, acts as a
precursor of a number of essential enzyme cofactors, such as nicotinamide adenine dinucleotide (NAD)
and coenzyme A, and is the source of the phosphoryl group in most kinase-mediated phosphorylation
reactions [1,2]. ATP is also used to synthetize cyclic adenosine monophosphate (cAMP), a major second
messenger involved in the regulation of numerous cellular processes.
A less known function for ATP is to act as an extracellular signaling molecule, allowing cells,
tissues, and organisms to communicate [3]. In addition, several studies during the last 30 years
show that extracellular ATP (ATPe) is involved in modulating a vast array of cellular functions,
such as neurotransmission, secretion of pro-inflammatory mediators, apoptosis, chemotaxis, cell
differentiation, and vasodilatation [3].
In cells and organisms, ATPe is subjected to a sophisticated system of regulation. At least four
processes are required to understand ATPe regulation at the cellular level: (1) ATPe, and/or some of
its breakdown products can interact with specific purinergic receptors (P receptors), thus triggering
ionotropic and/or metabotropic cellular responses [3]; (2) intracellular ATP can be released by cell
rupture (cytolysis) or by regulated mechanisms involving membrane transport proteins [4,5]; (3) ATPe
can be metabolized by specific membrane bound enzymes collectively called ecto-nucleotidases [6,7];
(4) full dephosphorylation of ATPe and other extracellular nucleotides leads to accumulation of
nucleosides, which promotes uptake of these molecules by nucleoside salvage mechanisms [8].
The mechanisms involved in ATPe regulation are usually cell type and species specific, and may often
change according to the pathophysiological context [3]. The picture turns even more complex during
parasite infection of targeted hosts [9,10].
At the evolutionary level, a continuous crosstalk exists between the parasite and the host leading
to adaptive changes allowing parasites to invade, grow and survive inside the host, in an attempt to
subvert host defense mechanisms to ensure development of the infection [11].
Such changes may include adapting host molecules, metabolic pathways and transporters for
their specific needs, and remodeling host membranes to avoid clearance. Moreover, parasites undergo
successive stages during their life cycle and may alternate between different hosts and tissues, resulting
in diverse combinations of host–parasite interactions. At the physiological level, on the other hand,
molecular, cellular and systemic adjustments can be relatively fast.
In humans, while transient increases of ATPe are involved in physiological signaling, strong
increases of ATPe concentration can occur in seconds, and serve as a danger signal in pathological
conditions, triggering a complex immunological and inflammatory response aimed at recognizing and
controlling intracellular pathogens [10,12]. In this context, infection by protozoan parasites has been
shown to alter host ATPe dynamics, by promoting changes in at least one of the above-mentioned
mechanisms controlling ATPe concentration. Protozoans may display their own set of proteins directly
altering ATPe dynamics or control the activity of host proteins. Parasite-dependent activation of
ATPe conduits [13,14] of the host may promote infection and systemic responses that are beneficial
or detrimental to the parasite [15–17], while protozoan ecto-nucleotidases can affect parasite growth,
infectivity and virulence [18,19]. Both actions on ATP efflux and ATPe hydrolysis mediate cellular
responses by altering the availability of nucleotide ligands involved in purinergic signaling of the host.
In this review, a special focus is given to protozoan proteins involved in mechanistic interactions
that regulate the homeostasis of ATPe and byproducts as well as the consequences of this regulation for
the parasite and the host. When information on specific protozoan proteins is scarce, a brief description
of related groups was included.
2. Purinergic Signaling
Signaling by P receptors appeared early in evolution as a form of chemical intercellular
communication, possibly with the first unicellular eukaryotic cells [2]. Further evolution in
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multicellular organisms resulted in the development of multiple classes of P receptors. Cloning of P
receptors [20] allowed for the production of polyclonal antisera for immunohistochemical studies of
their expression and distribution, showing that most receptors were located on the cell surface, though
in a few cases intracellular immunostaining was observed (see [21]).
The P indicates that these receptors can be activated by purine or pyrimidine nucleotides (P2)
or by the nucleoside adenosine (P1). P2 receptors are separated into two major subfamilies, P2X and
P2Y. Several comprehensive reviews summarize the accumulated knowledge on these proteins [3,22].
Cloned subtypes include seven P2X receptors (P2X1–7), eight P2Y receptors (P2Y1, P2Y2, P2Y4,
P2Y6, P2Y11–14) and four P1 receptors (A1, A2A, A2B, and A3) [23,24]. P2Y and P1 receptors are
metabotropic G-protein coupled receptors. Binding of di- or trinucleotides (P2Y) or adenosine (P1)
triggers second messengers which in turn will activate specific protein kinases coupled to downstream
signaling mechanisms [3].
As described in Section 4, extracellular metabolism of nucleotides facilitated by membrane bound
ecto-nucleotidases will enable the accumulation of several purine and pyrimidine di- and trinucleotides and
nucleosides. The effective concentration of these molecules at the cell surface will produce metabolic and
physiological responses by interacting with specific subtypes of P2Y and P1 receptors [25,26].
In contrast to P2Y and P1, P2X receptors are ionic channels activated only by ATPe, its only
natural ligand [22]. In this section, we will focus mainly on P2X receptors, since these are assumedly
the first to appear in protozoa, according to the limited but consistent genomic, pharmacological and
biophysical information [2,27]. Most P2X channels are cation-selective and discriminate poorly among
Na+, K+, and Ca2+, the main diffusible cations of eukaryotes. Transmembrane transport of these ions
is an important signaling mechanism, because it may alter the plasma membrane potential as well as
local ion concentrations [20].
Transcripts and/or proteins of P2X subunits have been found in most mammalian tissues and are
being increasingly discovered in several non-vertebrate species [28]. They exhibit a common topology with
two transmembrane domains, a large ATPe binding loop, and intracellular N-and C-termini of variable
lengths [29]. The ecto-domain is glycosylated and includes ten Cys residues conserved among all vertebrate
receptors, bound in five disulphide bridges contributing to the tertiary structure of the receptor [20].
P2X receptors are able to form homo-and heterotrimeric complexes [30,31] around a central
pore [32,33], and may be regulated by post-translational glycosylation and phosphorylation [34].
The trimeric structure was confirmed by atomic force microscopy, electron microscopy, single particle
analysis, and by crystallization of the P2X4 subtype from zebrafish [28], which agrees well with ion
conductance recordings suggesting that three molecules of ATP are required for channel gating [35,36].
2.1. P2X Receptors. Evolution and Early Appearance in Protozoa
As mentioned earlier, seven mammalian P2X cDNAs have been cloned [28]. Based on sequence
identity and pharmacological profile, most receptors of vertebrate species seem to be orthologs of
these receptors but low sequence homology has made difficult to determine potential homologues in
non-vertebrate organisms. Currently, no prokaryotic P2X receptor has been identified, suggesting that
structurally different ATP receptors evolved in bacteria [28,37]. P2X receptors appear to be absent in
several invertebrates such as Caenorhabditis elegans, Drosophila melanogaster, Anopheles gambiae, and Apis
mellifera [28], although extracellular nucleotides induce various cellular responses in tissues of these
animals [38]. On the other hand, P2X-like receptors were identified in the unicellular algae Ostreococus
tauri [39]. In vascular plants, although genomic sequence-based searches for canonical P2 receptors
failed to detect candidate ATP receptors [40], ATPe and other extracellular nucleotides are able to
trigger several cellular and systemic responses [41]. Recently, a lectin receptor kinase was found in
Arabidopsis thaliana, which binds ATPe with high affinity and is required for ATPe-induced intracellular
Ca2+ increase [40].
Alignment of P2X proteins from a diverse range of species suggests that the P2X1-7 receptor
subtypes resulted from a lineage-specific gene expansion [42]. Similar but independent lineage specific
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expansions of P2X receptor subtypes may have occurred in amoeba Dicthiosthelium discoideum and
algae O. tauri. D. discoideum possesses five P2X-like sequences, while O. tauri exhibits an identified P2X
receptor together with three further open reading frames encoding proteins assumed to be distantly
related to P2X receptors [43].
The protein sequences, kinetics and pharmacology of protozoan P2X-like receptors do not seem
to correspond to a specific P2X receptor subtype [39,43–45], which is not surprising considering
that development of the seven mammalian P2X receptor genes appeared to be a relatively
recent phenomenon occurring after the branching between vertebrates and invertebrates [28].
Sensing nucleotides has adaptive value for protozoans, since they control a wide range of different
processes like cilia beating, swimming, and chemotaxia in Paramecium [46] and Tetrahymena [47];
induction of parasitosis in Trypanosoma cruzi [48]; vacuole contraction in Amoeba proteus [49]; changes
in the cytoskeletal organisation in Physarum [50]; and phagocytosis in Dicthiosthelium [42].
2.1.1. A Brief Tale of Three Protozoans
Monosiga brevicollis
Choanoflagellates are among the closest unicellular relatives of animals and provide important
insights into the origin and diversity of animal phyla. These protozoa constitute the major component
of aquatic microbial foodwebs [27,51]. The genome of the marine choanoflagellate, Monosiga brevicollis,
has been sequenced in 2008 [52]. Because of horizontal gene transfer, >400 genes are likely derived
from algae and prokaryotes, accounting for ≈4% of Monosiga nuclear genome [52]. Interestingly,
among the 42 Mb genome containing approximately 9200 predicted protein coding genes, a P2X-like
receptor (named MBP2X) was detected. When expressed in human embryonic kidney cells (HEK-293),
MBP2X forms a functional ATP activated ion channel, which may be implicated in flagella driven
swimming or feeding of this organism [27], though a biophysical/phamacological characterization
remains to be performed.
Dictyostelium discoideum
A P2X-like gene encoding protein DDB0168616 appeared in D. discoideum [43], an amoeboid
species whose genome was fully sequenced in 2005 [53].
Expression of a humanized version of this cDNA in HEK-293 cells showed that this gene
(denoted as D. discoideum p2xA) encoded a membrane ion channel (DdP2X) activated by micromolar
concentrations of ATPe as well as slow-degradable ATP analogues [43]. In HEK-293 cells, ATPe elicited
whole-cell currents in a dose-dependent manner, with kinetic properties resembling human P2X2 or
P2X4 receptors, although typical purinergic blockers did not inhibit the response [43]. On the other
hand, site-directed mutagenesis revealed partial conservation of structure–function relations with
P2X receptors of higher organisms. For example, as in mammalian P2X receptors, two lysine residues
in the receptor ecto-domain contribute to ATP binding and a C-terminus YXXXK motif is involved
in receptor stabilization at the plasma membrane [33,43]. Moreover, expression of the recombinant
receptor in mammalian cells suggests conservation of trimer formation—similar to homologs of
vertebrates—by DdP2X [43]. A green fluorescent protein (GFP)-tagged version of DdP2X was localized
to the intracellular membranes of D. discoideum, mostly in the contractile vacuole, a specialized
organelle in osmoregulation. Thus, DdP2X functions on intracellular organelles, a feature observed in
mammal cells after constitutive or ligand-activated endocytosis of surface receptors [21]. DdP2X is
oriented with the ATP binding site facing the vacuole lumen, thereby being in principle able to sense
changes in luminal ATP. Targeted disruption of DdP2X resulted in cells being unable to regulate cell
volume when challenged by hypotonicity [43]. A similar P2X dependent regulation of cell volume can
be found in human red blood cells (RBCs), where surface located P2X receptors subtypes control cell
volume by modulating the net flux of cations [54,55].
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Interestingly, although DdP2X is strictly intracellular, D. discoideum also exhibits purinergic
signaling induced by extracellular purine nucleotides [42], i.e, exposure to ATPe or ADPe trigger
changes in intracellular Ca2+ content, which are comparable to the role for P2 receptors in vertebrate
cells [56]. More recently, Sivaramakrishnan and Fountain (2015, [57]) showed that Dictyostelium uses
ATPe to regulate cell volume. In most eukaryotic cells from multicellular organisms, swelling leads
to intracellular ATP release. The accumulated ATPe, and/or its metabolic byproducts, interacts
with P receptors mediating a decrease of cell volume [25,26]. Although a similar response sequence
is observed in D. discoideum challenged by hypotonicity, the genome of this protozoan yields no
information suggesting a putative cell surface P2 receptor [57].
Plasmodium falciparum, a Parasitic Protozoon
Plasmodium falciparum is the most dangerous etiological agent of human malaria [58].
After entering into the human body, P. falciparum first undergoes a developmental stage in the
liver before invading RBCs, where the parasite grows and matures [59]. Classical antimalarial therapy
is directed against the intraerythrocytic stage [60], which produces all symptoms of the disease [59].
The merozoite (parasite invading phenotype) invades the RBC and grows and replicates within the
parasitophorous vacuole (PV), undergoing development through well-characterized stages of ring,
trophozoite, and schizont. Subsequently, the infected RBC ruptures, releasing new merozoites that in
turn infect more RBCs [59].
Sequencing of the parasite genome [61] revealed approximately 60% of the predicted genes
not found in other organisms, thus hampering the search for homologous genes. This genomic
diversity is in part due to the extreme evolutionary divergence of the phylum Apicomplexa, but also to
species-specific features, with proteins in P. falciparum differing from those of the other closely related
Plasmodia species [62].
Plasmodia spp. employ unique proteins involved in highly specialized processes, such as passage
through blood vessels, evasion of the host immune system, and invasion and development within host
cells [63]. To facilitate intracellular growth, P. falciparum hijacks host organelles for nutrient uptake,
adapts the parasitophorous vacuole membrane (PVM) and the host membrane by exporting many
proteins, and increasing erythrocyte plasma membrane (EPM) permeability to a wide variety of organic
and inorganic solutes [64–66] (see Figure 1).
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mediated by several proteins like pannexin 1 (Pnx-1), anionic channels such as voltage-dependent
anion channel (VDAC) coupled to partner proteins, generic solute pores as plasmodial surface anion
channel (PSAC) and novel parasite proteins yet to be discovered. ATPe hydrolysis by red blood cells
(RBCs) E-NTPDases (ecto-nucleoside triphosphate diphosphohydrolases) is extremely low but strongly
increases under infection, though participation of parasite NTPDases at the host membrane remains to
be proven. Still, ATPe and its metabolic byproducts should be able to activate functional P1 and P2
receptors of the host, triggering intracellular signaling. In uninfected RBCs, part of this signaling was
shown to affect ATP efflux. On the other hand, accumulation of nucleosides (due to hydrolase activities
of E-NTPDases and CD73) will promote their uptake by host equilibrative nucleotide transporters
(ENT). Nucleosides will then transverse both unspecific vacuolar pores (Pore) of the parasitophorous
vacuole membrane (PVM) and PfENT1 of the parasite plasma membrane (PPM) to gain access to
the parasite. Nucleosides will then serve as substrates in the parasite pathway for de novo synthesis
of nucleotides. The parasite traslocon PTEX was shown to transport parasite protein(s) to the host
membrane, EPM, upregulating Ca2+ uptake. Once in the RBC cytoplasm, Ca2+ may be transported
through the parasitophorous vacuole (PV) by a calcium ATPase transporter, potentially reaching the
parasite cytoplasm through a P2X-like receptor conductance. On the other hand PTEX may be involved
in the translocation of parasite proteins to the NPPs, as e.g., PSAC.
The challenge for the parasite is to widely and unspecifically raise membrane solute traffic but
excluding Na+, whose permeability should be kept low to avoid RBC lysis. Different proteins were
proposed to be involved in these new permeability pathways (NPPs) induced by parasite infection.
Among them, in the last years new experimental data support a crucial role for the plasmodial surface
anion channel (PSAC) [66–68], associated with different proteins from Clag and RhopH families [67].
However, an alternative, non-exclusive hypothesis states that infection activates host proteins or
protein complexes, which were expressed but inactive or weakly active in the uninfected RBC [69].
Amongst inorganic ions with increased permeability, Ca2+ uptake proved to be the most critical
for intracellular parasite performance [63], since the P. falciparum expresses multiple Ca2+ effector
proteins like calmodulin, Ca2+-dependent protein kinases, phosphatases such as calcineurin, and other
Ca2+-binding proteins [70]. Early works have shown that both parasite invasion and the propagation
of in vivo infected RBCs cultures required the presence of extracellular calcium [71,72]. At rest,
P. falciparum, as most eukaryotic cells, exhibits submicromolar intracellular Ca2+ concentration [63].
However, intracellular Ca2+ concentration is highly increased when isolated parasites are treated with
ATP in the presence of extracellular Ca2+, thus suggesting an activation of Ca2+ influx. Moreover,
experiments in Ca2+ free medium abrogated the response, indicating that the parasite possesses an
ATP-gated calcium channel [15], a form of primitive P2X receptor (Figure 1). Similar responses were
obtained with Plasmodium yoelii and Plasmodium berghei (two species infecting rodents) [73]. Unlike in
the case of D. discoideum DdP2X receptor, a set of blockers (IP5I, PPADS, KN-62, TNP-ATP, and Suramin)
known to act on cloned vertebrates P receptors significantly inhibited the rise in ATPe-dependent
intracellular Ca2+ concentration. Surprisingly, extracellular UTP also induced intracellular Ca2+
deregulation in the parasite, a featured not observed in P2X1-7 receptors [15].
Several lines of evidence suggest that such P2X-like receptor of P. falciparum can be important
for parasite invasion to RBCs: (1) ATPe and Ca2+, but not other divalent cations triggered parasite
invasion [15,63] and ATPe-dependent intracellular Ca2+ concentration increase is required to ensure
the progress of the parasite life cycle [70]. (2) Under in vitro culture of RBCs with parasites, removing
endogenous ATPe by apyrase or pre-incubation with P2X blockers, drastically impairs parasite
invasion [15]. Interestingly in this context, exogenous ATP does not improve the efficiency of
RBC infection, suggesting that the putative P2X receptor should exhibit a relative high affinity
for ATPe. Alternatively, ATP affinity could be moderate, but receptor activation is possible in
light of experiments showing an increased ATP efflux from infected RBCs throughout the parasite
life cycle, which correlated with elevated ATPe concentrations in infected RBCs cultures with
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P. falciparum [14,74] and plasma samples from humans [75]. Once inside the RBC, P. falciparum
is enclosed in a highly permeable PVM, and exposed to the RBC cytoplasm containing a very low
intracellular Ca2+ concentration (<100 nM), which is much lower than in other cell types, and at least
3 orders lower than the millimolar Ca2+ concentration of the plasma. A very low Ca2+ concentration
environment set by the host is incompatible with parasite functions and survival and may hamper a
potential role of parasite P2X-like receptor in modulating ATP-dependent calcium influx [76]. In line
with this notion, Gazarini et al. [76] nicely demonstrated that P. falciparum and Plasmodium chabaudi
exhibit an active mechanism for Ca2+ accumulation in the immediate parasite microenvironment, with
concentrations of the cation amounting to 40 µM. This is much lower than plasma concentrations of the
cation, but nevertheless 100–1000-fold higher than that inside the parasite and in the RBC cytosol [77,78].
Thus, a Ca2+ gradient does exist between the relatively low intracellular Ca2+ concentration of the
parasite inside the PV and its external milieu, making a P2X-like receptor dependent Ca2+ uptake in
the parasite functionally relevant (Figure 1).
In addition, P. falciparum can activate Ca2+ influx of the RBC host. Early 45Ca2+ flux studies
indicated that net Ca2+ entry into infected RBCs was approximately 20 times faster than into uninfected
cells [79], which agrees well with the reported elevated Ca2+ conductance of patched membranes
from infected RBCs [80]. This increased accumulation rate could not be explained by inhibition of the
Ca2+ pump, a cell membrane ATPase that keeps the Ca2+ of uninfected RBCs very low. More recent
pharmacological studies suggested that the observed elevated Ca2+ permeability was mediated by a
new mechanism activated in the infected host cell [71]. I.e., when RBCs were infected with a parasite
knocked down for PTEX (a translocon for export of parasite proteins into the host cell), Ca2+ uptake was
highly reduced. Moreover, a cell-based high-throughput screen for specific Ca2+ transport inhibitors
confirmed a protein-mediated uptake mechanism on infected cells distinct from the low capacity Ca2+
carrier of RBCs [79] (Figure 1).
2.2. P receptors of the Host and Parasite Infection
Host organisms have evolved several mechanisms to control infection, while protozoa parasites
display several adaptations to evade host defense. P receptors of the host are often involved in this
fight [9,10,81].
Toxoplasma infects practically all mammalian cells [82]. Although most infections are
asymptomatic, they can cause serious problems when the immune system is compromised as with
pregnant women, AIDS patients or during congenital transmission [83,84]. Similarly to Plasmodia,
invasion results in the establishment of a subcellular PV. Success of the parasite depends on its ability
to rapidly reproduce inside the PV and then for its progeny to escape from the membranes of the
vacuole and that of the host cell, so as to invade more cells [85,86]. Following infection, the parasite
inhibits the fusion between lysosomes and the PV, maintaining the extravacuolar medium at a neutral
pH, thus allowing parasite survival [82]. However, ATPe ligation of P2X7 receptors restores that fusion,
acidifying the PV and leading to elimination of Toxoplasma gondii in macrophages [87,88]. In addition,
activation of P2X7 receptors in Toxoplasma infected macrophages increases the production of reactive
oxygen species [87,89] and induces apoptosis [88], another two host defense responses.
To the extent that host strategies require an efficient, fully functional P2X7 receptor,
polymorphisms at the P2X7 gene were shown to influence the susceptibility to toxoplasmosis in certain
human populations [90]. In particular, macrophages from people with the 1513C loss-of-function
single nucleotide polymorphism are less effective to kill T. gondii after treatment with ATP than
macrophages from people with the 1315C wild-type allele [88]. Thus P2X7 receptor activation of specific
polymorphic variants may influence the outcome of infection, no matter the route of transmission
or parasite genotype, which varies considerably worldwide [90]. In line, macrophages from P2X7
receptor knock-out mice are not able to eliminate the parasite as successfully as macrophages from
wild-type mice [88].
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Parasites may counteract P2X7 receptor mediated attack by secreting ecto-nucleotidases of the
E-NTPDase (ecto-nucleoside triphosphate diphosphohydrolase) family (see Section 4) before and after
host cell entry [91,92], to promote ATPe hydrolysis and therefore a decrease in P2X7 receptor activation.
As analyzed in Section 4, virulent T. gondii strains express the enzyme TgNTPDase 1, which possess
typical signal peptides for secretion and displays high ATPase activity [92,93]. At least theoretically,
TgNTPDase1 should be able to facilitate a decrease of ATPe concentration, thus lowering P2X7
receptor activity and dampening the inflammatory response. While this reasoning is still speculative,
compelling evidence has revealed an important role for E-NTPDases in P2X7 receptor activity by
controlling the effective ATP concentration at the cell surface, and the availability of ATPe during
infection-induced inflammation [94].
In addition to downregulation of P2X7 receptor activity, an increase ATPe hydrolysis by
TgNTPDase1 may have consequences on downstream purinergic signaling, by facilitating the
accumulation of extracellular AMP, and further degradation to adenosine by host ecto-5′-nucleotidase.
Elevated adenosine, in turn, may activate host P1 receptors. In contrast to ATPe, adenosine has
anti-inflammatory and immunosuppressive effects on immune cells [95,96]. Although neutrophils are
recruited during T. gondii infection [97], activation of P1-A2A receptors on these cells by extracellular
adenosine was associated with inhibition of activation and migration [98]. Moreover, infection
with T. gondii is lethal in mice deficient in 5′-ecto-nucleotidase, unless a potent P1 agonist is
administrated [99], and mice deficient in the adenosine receptor P1-A2A are more susceptible to
infection than wild type counterparts. Thus, production of adenosine by host 5′-ecto-nucleotidase,
probably facilitated by TgNTPDase 1 degradation of ATPe, leads to increased susceptibility of
mice to T. gondii infection. Several strategies of Leishmania are different from those of Toxoplasma.
Leishmania species are the ethiological agents of leishmaniases. Parasites are transmitted through the
bites of more than 90 different species of phebotomine sandflies, and have developed several strategies
to survive within the host by evading the immune response.
After invading macrophages by phagocytosis, Leishmania can survive within an acid pH
environment inside the phagolysosomes. In addition, Leishmania interferes with the production
of reactive oxygen and nitrogen species by phagocytes [100]. Macrophages infected with Leishmania
amazonensis exhibit higher expression of P2X7 receptors than noninfected cells [101]. ATP treatment
reduced parasite load [101,102] though not in macrophages isolated from P2X7 knockout mice [102].
In addition to P2X7 receptor modulation, infection with L. amazonensis up-regulates the expression
of P2Y2 and P2Y4 metabotropic receptors, which can be activated by either ATP or UTP [103]. This is
again a host antimicrobial response, since UTP decreases parasite load [104]. P2Y2,4 receptors signaling
involves intracellular Ca2+ mobilization, probably inducing apoptosis of infected cells as well as
production of reactive oxygen and nitrogen species [104].
As in the case of Toxoplasma infection, effects of adenosine on Leishmania parasitism were also
reported [105]. Patients with visceral leishmaniasis present higher concentrations of adenosine
in serum than healthy people [106]. For mice infected with Leishmania braziliensis, administration
of adenosine increased lesion development and tissue parasitism [107], while blockage of P1-A2B
receptors decreased lesion size and parasitic load [107]. In a murine model of Leishmania infantum
infection, P1-A2A receptor signaling reduced activation and migration of neutrophils, allowing the
establishment of infection [108].
An additional mechanism for regulation of host P2 receptors could involves desensitization,
which occurs in P2X1, P2X3, and P2Y1 receptors [21] by long exposure to their natural ligands.
Considering that parasite infection alters the kinetic profiles of extracellular nucleotide accumulation,
it may well regulate P2 receptors activity by affecting P2 desensitization. For instance, platelets
activation of P2Y1 by extracellular ADP highly mediates aggregation [109]. During P. falciparum
infection, strong ATP efflux of infected RBCs, together with a highly increased ATPe hydrolysis by
upregulated ecto-nucleotidases [14], should promote a strong enhancement of ADPe in the blood
stream. Under these conditions, platelets P2Y1 receptor may desensitize, and thus undergo a refractory
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state characterized by the inability to aggregate or change shape in response to extracellular ADP.
Changes in ATPe concentration may also affect desensitization of P2X1 receptor, causing abnormalities
in blood coagulation [109]. In patients with malaria, both hyperaggregation and defective aggregation
were described [110], though the contribution of extracellular nucleotides in this regulation needs to
be confirmed.
3. Transport of ATP
In cells and organisms multiple compartments exist from where ATP can be transported,
depending on the effective concentration, the available transmembrane ATP gradients (the driving force
for conductive ATP flux) and the capacity and kinetics of several proteins allowing ATP permeation.
Different cells from unicellular and multicellular organisms release ATP and other nucleotides
(ADP, UTP, and UDP) and adenosine during mechanical injury, necrosis, apoptosis, as well as under
various mechanical and chemical stimuli, such as shear stress, hypotonic swelling, stretching, and
different Ca2+-mobilizing agonists [111–114].
Most non-lytic mechanisms of ATP release were studied in mammals, where conduits for
regulated vesicular exocytosis or conductive nucleotide release via ion channels and transporters
were identified [54,55,113]. In principle, two main classes of plasma membrane channels have been
associated with ATP conductive activity: (1) Cl− channels such as the calcium homeostasis modulator
1 (CALHM1; [5]) channel, maxi-anion channels, volume-regulated anion channels (VRAC, also known
as volume-sensitive outwardly rectifying anion channel), and tweety [113,115,116]; and (2) pore
forming connexins and pannexin-1 (pnx-1). In addition, P2X7 receptor, alone or in association with
pnx-1, is known to progressively generate a large membrane pore that allows ATP permeation [117].
Other conduits such as the voltage-dependent anion channel (VDAC) were shown to interact with
partner proteins, like the 18-kDa-tranlocator protein (TSPO) and the adenine nucleotide transporter
(ANT). Thus, it soon become established that, although most Cl- channels are able to permeate
ATP to different extents [118,119], ATP transport may require these channels to operate as part of
multimolecular complex systems [120].
Evidence of ATP transport conduits of protozoa is scarce. In D. discoideum, ATP is released
following a hyposmotic challenge. Pharmacological evidence suggests an exocytotic mechanism,
but the implicated mechanisms were not identified [57]. D. discoideum appears to harbour an ATP
translocation mechanism to mediate ATP accumulation within the vacuole lumen. However, this is
not the source of the observed ATP release, since knockout cells with impaired contractile vacuole
fusion exhibited no inhibition of ATPe accumulation [57]. Irrespective of the mechanism, the resulting
osmotically induced accumulation of ATPe could signal auto/paracrinally through a putative cell
surface P2-like receptor [15].
Microsporidians are eukaryotic unicellular organisms living as obligate intracellular parasites
of vertebrates and invertebrates. Initially thought to be protozoans, recent molecular studies
indicate that the phylum Microspora should be more closely related to Fungi kingdom [121].
Recently, microsporidians have been reported to parasite humans, especially those immunologically
compromised [122]. These organisms have undergone massive gene loss in the transition to obligate
intracellular parasitism. Some of these genes encode proteins involved in purine and pyrimidine
biosynthesis, and the oxidative synthesis of ATP. On the other hand, glycolysis is highly down
regulated [123]. Thus, replicating parasites must import ATP from the host cell, using some kind of
transport system.
Microsporidian genome shows genes encoding for nucleotide transporters (NTTs) capable of
transporting ATP [124]. Three NTTs are located to the plasma membrane, while one is localized to
the mitosome, a remnant mitochondrial organelle [125]. Genome sequences of several microsporidian
species contain one or more of these transporters, probably acquired by lateral gene transfer from
intracellular bacterial pathogens [124], enabling early microsporidians to take up host ATPe for their
growth and biosynthesis processes. Expression in Escherichia coli suggests that NTTs display high
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affinity for ATP, while binding competition assays show that other nucleotides can be transported as
well. Clearly in this case, ATPe of microsporidian is the cytosolic ATP of the host. Signaling of ATP
might not be important in this case, but the energetic need for nucleotide salvage.
A similar strategy is used by protists living as endosymbionts of amoeba and paramecia, although
ATP transport involves an ATP/ADP exchange mechanism [126].
Genes coding for these exchangers were found in several species of Rickettsiae and Chlamydiae,
promoting import of host ATP through the prokaryotic cell membrane, which is otherwise impermeable
for relatively large anionic nucleotides, in exchange for ADP export into the host cytosol [126].
ATP-ADP exchange was also verified when expressed in a heterologous bacterial system.
Although in mammals such an ATP/ADP exchanger occurs exclusively in the inner mitochondrial
membrane, ANT has been observed in the plasma membranes of RBCs [120,127]. As we mentioned
previously, ANT may physically associate with VDAC and other proteins at the RBC cell membrane,
to form a conduit capable of exporting ATP to the extracellular milieu [120].
In Plasmodia, ATP and other organic anions were proposed to be transported by the NPPs, though
the molecular identity of this pathway is a matter of debate. However, it was recently reported that
drug ligands modulating VDAC activity were able to induce ATP release from RBCs [120,128], and that
P. falciparum infection induced changes in the affinity of RBC membranes for these drug ligands [69].
In protozoan parasites, use of host ATP is qualitatively different to microsporidians and protists
parasites, in that ATP and other nucleotides are first dephosphorylated by ecto-nucleotidases to
nucleosides, purines, and pyrimidines. Specific nucleoside transporters allow uptake of these
compounds into the parasite, which can then be used to resynthesize ATP and nucleic acids (see
Section 5).
In many cells and organisms, hypoxia and anoxia constitute potential stimuli promoting regulated
ATP release by vesicular and conductive mechanisms [129–132]. In human RBCs, hypoxia-induced
ATP release is mediated by pnx-1 [133], although other stimuli can activate different ATP conduits in
these cells [54,55,128].
Interestingly in this context, Leishmania promastigotes (the flagellated phenotype) were shown
to induce non-lytic release of intracellular ATP, but not of other nucleotides, when challenged by
anaerobiosis [134]. The accumulated ATPe may have various fates. On the one hand, Leishmania or
host derived ATPe might activate parasite killing by activation of P2X7 receptors of macrophages [101].
Alternatively, ATPe may be degraded by Leishmania NTPDases, as part of a mechanism for purine
salvage ([135]; see Section 5).
In addition, ATPe may participate in the phosphorylation of extracellular proteins, affecting the
interaction of the parasite with the host’s immune system. Accordingly, exogenous ATP was shown to
phosphorylate added histone and several parasite surface proteins, including tubulin [136].
4. Ecto-Nucleotidases
Ecto-nucleotidases are plasma membrane-associated nucleotidases that usually display their
active site to the extracellular space, although cleaved and soluble extracellular isoforms may
occur [137]. The currently known ecto-nucleotidases include members of the E-NTPDase family
(ecto-nucleoside triphosphate diphosphohydrolases), hydrolyzing extracellular nucleoside 5′ di-and
triphosphates, E-NPP (ecto-nucleotide pyrophosphatase/phosphodiesterases), which can hydrolyze
pyrophosphate 5′-monodiester bonds in ATP and dinucleoside polyphosphates; ecto-alkaline
phosphatases, acting as non-specific phosphomonoesterases; and ecto-5′-nucleotidases, also called
CD73, which hydrolyse only nucleosides monophosphates [6]. Extracellular adenosine can thereafter
be either inactivated by cell surface associated adenosine deaminase (ADA) and purine nucleoside
phosphorylase (PNP; [114,138,139]) or transported into the cell by equilibrative or Na+-dependent
nucleoside transporters in order to replenish the intracellular nucleotide pool, as discussed in
Section 5 [140,141].
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In different organisms, the relative contribution of different ecto-nucleotidases to the regulation
of extracellular nucleotides depends not only on the availability and preference of substrates, but
also on their cell and tissue distribution [34]. Hydrolysis of ATPe and other extracellular di- and
trinucleotides is mainly promoted by different E-NTPDase subtypes, which are ubiquitously expressed
in eukaryotes [6,142]. To date there are eight members of this family. NTPDases 1, 2, 3, and 8
are expressed as cell surface locate enzymes, with the catalytic site facing the extracellular milieu.
NTPDases 5 and 6 are intracellular, but can be proteolitically cleaved and secreted, while NTDPases 4
and 7 are intracellular with the active site facing the lumen of organelles [6,114,137].
All E-NTPDases are highly glycosylated, integral membrane proteins, which require
intracellular Ca2+ or Mg2+ for enzyme activity [114,143]. All members share five highly
conserved sequences of amino acids called apyrase conserved regions (ACRs), which are essential
for enzyme function [137,144–147], and may exist either as monomers or homo-oligomers [6,137,147].
Site-directed mutagenesis studies of conserved amino acid residues in ACRs regions show that,
depending on the amino acid being altered, site mutations resulted in inactivation or activation of
enzyme activity [147,148], while significant changes in the kinetic features are possible with only a few
changes in the amino acid sequence of the ACRs [148].
The different subtypes of E-NTPDases differ in their preference for nucleotide 5′-tri-and nucleotide
5′-diphosphates, displaying broad substrate specificity towards different purine and pyrimidine di-
and trinucleotides, with Km values ranging from 50 to 200 µM [7]. These values should be taken
with caution, since the catalytic properties and nucleotide preferences obtained in vitro with enzymes
purified to different extents and with different detergents may not match the in vivo kinetic features
of membrane bound enzymes. In COS7 cells transfected with cDNA coding for human and murine
E-NTPDases 1, 2, 3, and 8, most apparent Km values for these enzymes were in the low micromolar
range [143].
For each system and a specific metabolic status, the rate of nucleotide to nucleoside conversion is
relevant, since it determines the effective time a given nucleotide is available to interact with specific
P receptors before being locally hydrolyzed by ecto-nucleotidases. In several cell types [149,150],
E-NTPDases may act in concert with the 5′-ecto-nucleotidase to achieve the sequential and complete
dephosphorylation of ATPe to adenosine. The 1-8 classification of the E-NTPDase family was mainly
derived from studies on animal tissues [151], but—as we will see below—evolutionary earlier forms
of these enzymes may differ in various structural and kinetic aspects. The gene family has members
in various protozoan species [92,144], as well as in plants and yeast [92,137]. Sequencing of several
genomes of protozoan parasites revealed the presence of genes encoding putative NTPDases [92]; [152].
However, as pointed out by Nakaar et al. ([153], see also [92]), it is sometimes difficult to clarify
which gene encoding a putative NTPDase, or else another nucleotidase, is responsible for the observed
nucleotide hydrolysis.
A few well-known protozoan models will be analyzed below, with particular focus on pathogenic
species of genera Toxoplasma, Trypanosoma, and Leishmania.
In the last 25 years, evidence has been accumulating that expression of E-NTPDase genes
is required for virulence of many pathogens [93,154–157]. Thus it appears likely that protozoan
NTPDases, by altering the concentration of ATPe and other extracellular nucleotides accumulating on
the cell surface of hosts may interfere with P signaling to suppress inflammatory responses and evade
immune reactions [154].
4.1. Toxoplasma gondii
T. gondii encodes three sequences compatible with E-NTPDases on its genome [84], although
cDNA analysis showed that only genes for TgNTPDases 1 and 2 [92], also termed NTPDases 3 and 1,
respectively [84], are transcribed and translated. Amino acid sequences of both enzymes contain the
canonical five ACRs, demonstrating that they are members of the E-NTPDase family. Despite 97%
identity, both enzymes displayed different affinities for di- and trinucleotides, with TgNTPDase 1
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exhibiting more than four-fold higher ATPase activity than TgNTPDase 2 [84,93,158]. Most virulent
strains of T. gondii possess the gene encoding TgNTPDase 1, but avirulent strains carry only the gene
encoding TgNTPDase2 [93,159]. Early studies showed that TgNTPDase 1 inhibition by antisense
RNA compromised parasite replication, while pre-treatment of parasites with a monoclonal antibody
inhibiting TgNTPDases 1 and 2 compromised invasion of the parasites into host cells, suggesting that
NTPDase activity (one or both isoforms) is essential for parasite function [84,153,158].
Antibodies raised to recombinant NTPDases enabled localization of the enzymes within the
parasite and during infection of host. Accordingly, TgNTPDases 1 and 2 are secreted into the lumen of
the PV [160,161]. TgNTPDase 1 has only low levels of expression in the bradyzoite form of the parasite
(the form responsible for chronic host infection) but is highly expressed in secretory granules of the
actively replicating tachyzoite form [92,158].
Whether TgNTDPase activity contributes to the invasion of the parasite, and/or egress from the
host, remains controversial [92,153,162]. As ATPe from the host can activate specific P2X7 receptors [12]
to promote inflammation, we might assume that T. gondii NTPDases might likely interfere with the
host inflammatory response. However, the intracellular location of TgNTPDases and their millimolar
Km values [84] argue against this hypothesis. Alternatively, a role in purine salvage has been
proposed. This is because TgNTPDase2 hydrolyzes ATP and ADP at similar rates. If coupled to
host 5′-ecto-nucleotidase activity and other downstream ecto-enzymes, it may produce adenosine and
by-products capable of being transported to the parasite (see Section 5) [163].
In the closely related Neospora caninum, NTPase (NcNTPDase) lacks nucleoside diphosphate
hydrolase activity and appears to be more abundant in virulent isolates, suggesting a role in
the pathogenicity of neosporosis, which causes abortion in cattle and neuromuscular disorders
in canids [164]. Protein dynamics, secretion, and mRNA expression profiles and enzyme
immunolocalization during the tachyzoite lytic cycle was compatible with NcNTPase, similarly to
TgNTPDase, being localized in dense granules and the PVM throughout the lytic cycle. Up-regulation
and secretion of NcNTPDase occurred during the egress and early invasion phases.
4.2. Trypanosoma cruzi
T. cruzi is the ethiological agent of Chagas disease, commonly spread to humans and more than
100 species of mammals by hematophagous triatomine insects. It is a cause of morbidity and mortality
not only in endemic areas of North, Central, and South America but also among immigrants now
residing in non-endemic areas of the world [165]. Up to date there are no vaccines or effective treatment
for the disease [166]. Vector control is the most effective method of prevention. Blood screening is
necessary to prevent infection through transfusion and organ transplantation [167].
Parasites circulate through the blood of the host in the form of trypomastigotes. When the
triatomine insect bites and feeds on infected blood, the trypomastigote matures and differentiates
to the epimastigote form, which attaches to the intestinal wall and divides. Three to four weeks
later epimastigotes convert to infective trypomastigotes that move to the hindgut of the insect.
Transmission to the new host occurs when parasites from insect feces enter cells at bite wound
sites [165]. Parasite initially replicates within local tissues before disseminating in the bloodstream,
where they can infect at distal sites [165].
T. cruzi encodes a single predicted NTPDase (TcNTPDase) containing all five ACRs. The fact that
a protein on the parasite surface reacted with a specific antibody anti TcNTPDase suggests the surface
localization of the enzyme, although a predicted N-terminal signal peptide may allow the enzyme to
be secreted [168].
A recombinant form of TcNTPDase promoted hydrolysis of ATP and ADP, with an ATPase:ADPase
ratio of approximately 2, i.e., similar to that of E-NTPDase 1 of mammalian models [166]. However,
although E-NTPDase activity was clearly shown by exposing intact live parasites to extracellular
nucleotides, problems arise when trying to assign the experimentally measured ecto-nucleotidase
activities to the identity of the enzymes. For example, the ATPase:ADPase ratio was shown to vary
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during passage in culture, changing from 2:1 for trypomastigotes to 1:1 for epimastigotes. Moreover
ARL67156, a generic ecto-nucleotidase inhibitor, partially inhibited ATP diphosphohydrolase activity,
but failed to inhibit recombinant TcNTPDase [166]. On the other hand, gadolinium and suramin
caused decreased infectivity in vitro and decreased virulence in a mouse model of disease [92,166],
but these compounds may also interfere with ATP transport mechanisms and P receptor signaling
([157,159,169,170], see also [171]). Nevertheless, the fact that ecto-nucleotidase activities could be
measured in vitro using different nucleotides (GDP, GTP, UDP, and UTP) suggests the participation of
one or more NTPDases [172,173]. Moreover anti-TcNTPDase 1 polyclonal antiserum was shown to
partially inhibit ATPDase activity and infectivity of trypomastigotes [166]. In addition to NTDPase
activities, in vitro experiments showed that T. brucei has the ability to hydrolyse extracellular AMP to
adenosine, indicating 5′-ecto-nucleotidase activity in this parasite [174].
More recently, Santos et al. [166] showed that high ratio of ATP/ADP extracellular hydrolysis is
important to maintain the capacity of parasites to infect mammalian Vero cells lines (carcinoma-derived
African green monkey fibroblast cells). Moreover, inhibition of parasite NTPDase modulated the
infectivity and virulence in mice, suggesting that this enzyme might facilitate T. cruzi infection.
In contrast to T. cruzi, T. brucei is an extracellular pathogen that replicates in the bloodstream
of mammals [175], causing African sleeping sickness. The genome of T. brucei encodes 2 predicted
NTPDases containing N-terminal signal peptides, implying secretion by the parasite [176]. When intact
parasites were exposed to exogenous nucleotides, hydrolysis of ATP, GTP, CTP, UTP, and ADP was
found. In principle, the availability of efficient RNAi systems in T. brucei could be used to assess the
importance of these enzymes in virulence [177].
4.3. Leishmania
The genome of five Leishmania species possesses two predicted NTPDases, containing the five
ACRs [178] but no kinetic characterization of these enzymes is available. One putative E-NTPDase
exhibits a predicted N-terminal transmembrane domain, compatible with anchoring of the enzyme
on the membrane of the cell or that of an intracellular organelle. Another putative Leishmania
NTPDase has a predicted N-terminal signal peptide, suggesting a potential secretion of the protein
that could be responsible for extracellular nucleotide hydrolysis [179]. While it is not confirmed that
the observed enzyme activity is due to members of the NTPDase family, the kinetic characterization is
in principle consistent with the presence of NTPDases, although the enzymes identified in L. tropica
and L. amazonensis cannot utilize Ca2+ instead of Mg2+, which is unusual for the E-NTPDase
family [156,180].
In several Leishmania species ATP can be hydrolysed to adenosine at the cell surface, indicating
the presence of NTPDase and 5′-ecto-nucleotidase activity [135]. Nucleotidase activity is higher
in virulent strains than avirulent strains and is increased more than 10-fold in the obligate
intracellular amastigote stage [155,156]. On the other hand, treatment of parasites with anti-CD39
antibody (i.e., cloned E-NTPDase 1) reduced the interaction of the parasites with mouse peritoneal
macrophages [156], further suggesting a role for an NTPDase in pathogenesis. Moreover, the expression
of ecto-nucleotidases in Leishmania is linked to lesion size upon infection, with high expression of these
enzymes associated to decreased immune response and bigger lesions [18].
4.4. Plasmodium falciparum
Recently Borges-Pereira et al. [181] provided the first characterization of an NTPDase of P.
falciparum. In this species, the genome predicts a gene encoding a putative E-NTPDase (Pf apyrase,
PF3D7_1431800). ATPase activity as well as mRNA levels were confirmed at all stages of development,
i.e., rings, trophozoites and schizonts. In isolated parasites, ATPe hydrolysis was inhibited by
well-known E-NTPDase inhibitors, which strongly impaired parasite development. Expression of a
N-terminal PfNTPDase-GFP chimera suggested that the NTPDase is expressed throughout the asexual
cycle, but localization appears to change from the endoplasmic reticulum to the digestive vacuole
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as the parasite develops. Since the chimera lacks the C-terminal transmembrane sequence, the exact
localization of the enzyme awaits confirmation [181]. Enzyme kinetics results suggest that PfNTPDase
might translocate to the host membrane. This is because uninfected RBCs have a very low ATPe
hydrolysis rate by ecto-ATPase activity, while infected RBC displayed several fold higher values at all
stages [14]. Moreover, ecto-ATPase activity of trophozoite infected RBCs is approximately 400-fold
higher than similar activity of uninfected cells, both at low nanomolar as well as high micromolar
ATP concentrations [14]. This finding supports the hypothesis that infected cells express higher levels
of functional ecto-nucleotidases than uninfected cells. Up-regulation of host E-NTPDase is unlikely,
since mature RBCs lack nucleus and thus the synthesis of new proteins is restricted to the translation
of pre-existing traces of mRNA. Elevated host E-NTDPase may be partly explained by a decreased
degradation rate of the infected RBCs and/or posttranslational modifications. In this line, we observed
before [14] that trophozoite infected RBCs can highly produce nitric oxide, which modulates host ATPe
hydrolysis rate, probably by S-nitrosylation of E-NTPDase. Alternatively, PfNTPDase or an unknown
parasite nucleotidase, might account to the observed elevated ecto-ATPase activity of infected cells.
An evolutionary tree depicting the evolution of NTPDases is shown in Figure 2 (sequence
alignment of NTPDases are given in Figure S1). Evolution of NTPDases from humans and other
vertebrates shows a clear separation of subtypes locating at the cell surface (i.e., NTPDases 1–3,
8) or intracellularly (i.e., NTPDases 4–7), which correlates well with the topological and structural
differences between the two groups [6]. In fact, hNTPDase1 and hNTPDase2 proved sufficiently
related to form catalytically active protein chimeras [6].
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Figure 2. Radial phylogenetic tree from amino acid sequences of NTPDases. NTPDases from protozoan
species are shown, together with NTPDases from other vertebrate species and a bacterium. The tree was
generated using the ClustalW sequence alignment tool, with the resulting tree being built with the MEGA-X
software, using the Neighbor-Joining method. Visualization was done with the program Figtree. The tree
was drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to
infer the phylogenetic tree. The evolutionary distances were computed using the Poisson correction method
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and are in the units of the number of amino acid substitutions per site. NTPDases and
their accession numbers are listed as follows. Human NTPDases: hNTPDase 1: NP_001767,
hNTPDase2:NP_982293, hNTPDase3:NP_982293, hNTPDase4:NP_004892, hNTPDase5:NP_001240,
hNTPDase6:NP_001238, hNTPDase7:NP_065087, hNTPDase8:NP_001028285. Danio rerio NTPDases:
DrNTPDase 2:54261809, DrNTPDase 3: ABR15509, DrNTPDase4:50539906, DrNTPDase 6:62955697,
DrNTPDase 8:268837940. Xenopus tropicalis NTPDases: XtNTPDase5:301618468, XtNTPDase7:62859996.
Protozoan NTPDases for Plasmodium falciparum (Pf): PfNTPDase:AAN36910; Toxoplasma gondii
(Tg): TgNTPDase 1: Q27893, TgNTPDase 2:Q27895; Toxoplasma brucei (Tc): TbNTPDase:
XP_847211; Leishmania major (Lm): LmNTPDase1: XP_001681917, LmNTPDase2:CAJ02396;
Leishmania donovani (Ld): LdNTPDase1:CBZ32820.1, LdNTPDase2:CBZ32136.1; Leishmania infantum
(Li): LiNTPDase1:XP_001464341, LiNTPDase2:XP_001463665; Trypanosoma cruzi (Tc): TcNTPDase:
AA575599; Neospora caninum (Nc): NcNTPDase: BAA31454. Aligments of aminoacid sequences of
NTPDases are given in Supplementary Figure S1.
Similarly to vertebrates, all protozoan ecto-nucleotidases are denoted in the tree as NTPDases,
as they contain the five ACRs. As expected, species from Euglenozoa (Trypanosoma and Leishmania)
showed evolutionary proximity, and the same is true for species from Apicomplexa (Toxoplasma,
Neospora and Plasmodium). Toxoplasma and Neospora NTPDases are consistently grouped, as TgNTPases
1 and 2 share 97% identity, while N. caninum exhibit 69% identity with TgNTPDase 1 [92]. Most bacteria
lack NTPDases, but NTPDase from Legionella pneumophila, a pathogenic bacterium, was possibly
acquired by horizontal transfer [6].
5. Nucleoside Transport
Although ATPe and other extracellular nucleotides are usually not taken up by cells,
dephosphorylated nucleoside derivatives interact with specific transporters to enable intracellular
uptake via specific nucleoside transporter proteins (NTs).
There are two different gene families of NTs [182]. In humans, the SLC28 gene family
encodes Na+ dependent concentrative nucleoside transporters, with three isoforms (CNT1–3) [182],
whereas the SLC29 gene family encodes nucleoside transporters comprising four isoforms in
humans called equilibrative nucleotide transporters (ENT) 1–4. ENTs are glycosylated, possess 11
transmembrane helices with cytoplasmatic N-and extracellular C-termini, a large extracellular loop
between transmembrane domains 1 and 2, and a large intracellular loop connecting transmembrane
domains 6 and 7. First thought as being exclusively equilibrative transporters of nucleosides,
later findings show that some family members also transport nucleobases whereas others act as
proton-dependent concentrative transporters [183–186].
Recycling of nucleosides and nucleobases by NTs is essential for the synthesis of nucleotides and
nucleic acids, intracellular signaling pathways (e.g., cAMP, cGMP), and phospholipid synthesis.
In particular, adenosine uptake can modulate P signaling, in that it decreases the effective
adenosine concentration at the cell surface, thereby terminating its action on P1 receptors [187].
Nucleoside uptake and subsequent intracellular anabolic reactions can also improve the energetic state
of a cell, which sometimes translates into higher intracellular ATP concentrations. This is especially
important for conductive ATP release (see Section 3), where intracellular ATP acts as the main force
driving the efflux of this nucleotide [113] by protozoan and host transporters.
Following the first molecular characterizations of ENTs in human tissues (1997, in [188]),
the identification of homologous proteins by functional cloning and genome analysis has revealed that
the family is widely distributed in eukaryotes [188]. In several protozoa, nucleoside and nucleobase
transporters are ENT family members displaying the canonical eleven transmembrane domains [189].
Structure–function relationships of parasitic protists have been reviewed recently [189]. Two NTs,
LdNT1 and 2, were found in cell membrane of Leishmania donovani, transporting adenosine and
pyrimidine nucleosides (LdNT1) and inosine and guanosine nucleosides (LdNT2) [189]. Interestingly,
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these transports exhibited a 100-fold higher affinity for their substrates than mammalian NTs,
thus enabling an efficient use of intracellular nucleosides from the host. Expression in Xenopus
oocytes showed LdNTs to use a proton gradient for secondary active transport of nucleosides, i.e.,
a concentrative mechanism qualitatively different from passive equilibrative transport of mammalian
ENTs. Mutational analysis showed that a single amino acid substitution can affect substrate specificity,
as substitution G183D in a transmembrane domain decreased adenosine transport, while G183A
impair pyrimidine transport [189].
In Trypanosoma brucei, ENT transporters, include TbNT1 transporting adenine and adenosine and
TbNT2-10 transporting purine nucleosides and nucleobases [183,190,191].
A low affinity adenosine ENT transporter was found in T. gondii, which may couple well with
ecto-nucleotidases, since TgNTPDase 1 (see Section 4) promotes ATP and ADP hydrolysis at similar
rates, producing AMP, which may then be a substrate of ecto 5′-nucleotidases producing adenosine,
which can then be scavenged by ENT for growth [84].
Purine Salvage of Parasitic Protozoa
Most genetic and molecular studies on ENTs have been done in parasitic protozoa, which usually
lack the early ATP-dependent steps in the de novo biosynthesis of purines [192] and hence import
the missing substrates using ENTs. The need to grow rapidly imposes an energetic burden to these
organisms, which require ATP as a source of energy and large amounts of purines for DNA and RNA
synthesis. Several reports showed that functional ENTs transporters allow parasites to salvage a wide
range of nucleoside and nucleobases from the host, later used to synthetize nucleotides within the
parasite [183,193]. Proteins participating in the transport and metabolism of purine nucleosides differ
considerably between the human host cells and protozoa, making this pathway a potential target for
drug development [8,194,195]. In contrast, parasitic protozoa are capable of synthesizing pyrimidines,
with the exception of Giardia lamblia, Tritrichomonas foetus, and Trichomonas vaginalis [196].
In mature human RBCs infected with Plasmodia, nucleoside transport and metabolism is more
complex, as these host cells lack purine and pyrimidine biosynthetic pathways [197], and therefore
largely depend on nucleoside uptake by human ENTs (hENTs). During the intraerythrocytic life cycle
of the parasite, purine transport activity of hENT is complemented by the activation of NPPs, thus
ensuring the entrance of nucleosides—and other nutrients—in the cytosol. Hypoxanthine, inosine
and adenosine are transported across the PV through unspecific pores [8,198], and then taken up
through NTs located at the plasma membrane of the parasite. Although four putative transporters
(PfNT1-4) were identified in P. falciparum genome, isoform 1 is mainly used for purine salvage [192].
Accordingly, protein mass spectrometry shows that PfENT1 is expressed at all parasite stages, while
PfENT1 knockout parasites are not viable in RBC cultures containing micromolar concentrations of
purines similar to those found in plasma [192]. Moreover, genetic disruption analysis confirmed
that the PfNT1 gene is essential for purine nucleoside uptake and parasite survival. Once inside the
parasite, a series of enzymes such as N-ribosyltransferases and phosphotransferases will metabolize
host purines to supply parasite needs.
6. Summary and Conclusions
ATPe dynamics of protozoan parasites was studied in terms of the proteins involved in purinergic
signaling, transport and metabolism of ATP and purine salvage, with special focus on the role of
protozoan proteins. Existing data show that the relative contribution of parasites versus host proteins
in mediating these processes is still controversial.
Although extracellular nucleotides are known to mediate a wide range of metabolic and
physiological processes in these organisms, only a few protozoan P2X-like receptors were described,
with the most studied case being the DdP2X receptor of D. discoideum. A gene was identified encoding
a P2X-like protein. Site directed mutagenesis studies, together with assessment of whole cell currents
showed conservation of structure and function of a typical P2X channel. DdP2X appears to localize
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exclusively in an intracellular vacuole, with the ATP binding site in the lumen [57]. It remains to be
seen if this intracellular localization of the receptor, possibly sensing and reacting to intravacuolar ATP,
is also observed in other protozoa. Adaptation of the parasite host sometimes required up-regulation
and/or activation of P2 receptors, especially P2X7 receptor involved in antimicrobial responses.
In addition, polymorphisms of P2X7 receptor were identified in humans that influence the outcome of
infection to toxoplasmosis, no matter the parasite genotype [90].
Only in the case of protozoan ecto-nucleotidases there is ample molecular, kinetic, and cellular
information from various protozoan species, both studied in isolated conditions or interacting with
their host. In most studied species, predicted NTPDases encoded in the genomes were found. Enzymes
were shown to either remain attached to the parasite membrane as ecto-enzymes, or be released to
their extracellular milieu. Parasite NTPDases contributed differently to ATPe regulation depending on
substrate availability, the kinetic characteristics of the enzyme(s) and the localization and interaction
with the host. In general, NTPDase activity seems to correlate with the virulence strength of the parasite
strain. A role for these enzymes is clearly shown in Leishmania, where antisense RNA and antibodies
raised against parasite NTPDases impaired replication and compromised host invasion [84,153,158].
Whether parasite NTPDase activity interferes with the host inflammatory response and plays a role in
purine salvage should be studied in more detail.
ATPe and by products not only signal through purinergic signaling, but following
ecto-nucleotidase activity they can be degraded sequentially to nucleosides and purines. In the
metabolic competition of parasites and their hosts, parasites developed high performance purine
salvage mechanisms, which are especially important for apicomplexan purine auxotrophs [192].
Two main strategies evolved in protozoa. First, as shown in L. donovani NTs, nucleoside uptake is
driven actively, by means of a proton gradient [183,185]. This is unlike mammalian NTs taking purines
by facilitated diffusion, which makes their activity dependent on building a favorable transmembrane
gradient. Second, parasite NTs may have a several fold higher affinity for their substrates than
mammalian counterparts [189].
An illustrative example of the multiple interactions of ATPe dynamics of P. falciparum infected
human RBCs is shown in Figure 1, where both parasite and the host are purine auxotrophs.
For these and yet to discover protozoan proteins, bioinformatic tools, the design of specific
ligands as well as co-immunoprecipitation studies are required to identify putative interacting proteins
forming functional enzymes, receptors and transporters. Moreover, trafficking of parasite proteins
to the host cell membrane deserves further investigation [68]. From a medical perspective, high
throughput screening of potent and specific inhibitors against targeted parasite proteins might aid in
finding drugs that kill parasites effectively, and have appropriate absorption, distribution, metabolism,
and safety in humans [68].
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4425/10/1/16/s1,
Figure S1: Sequence alignment of NTPDases used to build the evolutionary tree of Figure 2.
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